KSH International Regulatory Approval

KSH International Business Update

KSH International received PGCIL manufacturer approval to produce CTC, PICC, and BPICC for 765 kV transformers/reactors. The Supa Facility can now supply conductors for POWERGRID projects.

KSH International Board Meeting Date

KSH International will hold a board meeting on November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.

KSH International Management Change

KSH International appointed Mr. Amitabha Mukhopadhyay as an Additional Non-Executive Independent Director. Mr. Ajay Shriram Patil resigned as an Independent Director.

KSH International Annual General Meeting

KSH International Limited held its 47th Annual General Meeting on September 15, 2026, and has submitted the summary of proceedings to the exchange.

KSH International Production Started

KSH International Limited received Consent to Operate from the Maharashtra Pollution Control Board. This approval enables a total manufacturing capacity of 28,800 MTPA at its Supa Facility.

manufacturing capacity

28800.0 MTPA

KSH International Business Update

KSH International received Consent to Operate for its Supa facility from the Maharashtra Pollution Control Board. The approved capacity is 28,800 MTPA for magnet winding wires.

manufacturing capacity

28800.0 MTPA

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.